-
Je něco špatně v tomto záznamu ?
Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis
Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.
Jazyk angličtina Země Velká Británie
Grantová podpora
NB7099
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
- MeSH
- časové faktory MeSH
- chronické selhání ledvin krev metabolismus MeSH
- dialýza ledvin MeSH
- financování organizované MeSH
- ghrelin MeSH
- IGFBP-3 metabolismus MeSH
- index tělesné hmotnosti MeSH
- insulinu podobný růstový faktor I metabolismus MeSH
- kreatin krev MeSH
- ledviny metabolismus MeSH
- leptinové receptory MeSH
- lidé středního věku MeSH
- lidé MeSH
- peptidové hormony chemie krev metabolismus MeSH
- protein 2 vázající insulinu podobné růstové faktory metabolismus MeSH
- receptory buněčného povrchu chemie MeSH
- renální insuficience krev MeSH
- růstový hormon metabolismus MeSH
- statistické modely MeSH
- studie případů a kontrol MeSH
- zvířata MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
Ghrelin was originally isolated from the rat stomach and significant amounts were found also in the kidney. Present study was designed to examine changes in ghrelin levels in renal failure and their relationship to the GH/IGF-I axis. Fourty patients with mild-to-severe CRF (19 men, 21 women, aged 62.5 +/- 2.2 years, BMI 27.57 +/- 0.73 kg/m(2)) and 34 healthy control subjects (17 men, 17 women, aged 60 +/- 2.6 years, BMI 27.55 +/- 0.79 kg/m(2)) were included in the study. Total ghrelin levels were significantly increased in patients with chronic renal failure (CRF) (p < 0.0001). Total ghrelin in CRF correlated positively with active ghrelin (p < 0.001), GH (p < 0.05), IGF-I (p < 0.05), free IGF-I (p = 0.0001), IGFBP-3 (p < 0.01), IGFBP-2 and -6 (p < 0.05). Active ghrelin in CRF correlated positively with IGF-I (p < 0.001), free-IGF-I (p < 0.005), IGFBP-2 (p < 0.05) and IGFBP-3 (p < 0.05). However, most of the correlation were markedly reduced and the significance disappeared after adjustment for different creatinine levels. Hemodialysis in patients with end stage renal disease (ESRD) resulted in a significant reduction of plasma total and active ghrelin (p < 0.01 and p < 0.001 respectively). In conclusion we demonstrated elevated plasma levels of total ghrelin in CRF, and a reduction of total and active ghrelin after a single course of hemodialysis in ESRD. The elevation of ghrelin levels could be caused by impaired clearance and/or metabolism of ghrelin in the kidney. We did not prove clearly significant relationship between ghrelin serum levels and parameters of GH/IGF-I axis in study subjects.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07520181
- 003
- CZ-PrNML
- 005
- 20130225090354.0
- 008
- 090327s2005 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Jarkovská, Zuzana $7 xx0056683
- 245 10
- $a Plasma levels of active and total ghrelin in renal failure: a relationship with GH/IGF-I axis / $c Jarkovská Z, Hodková M, Sazamová M, Rosická M, Dusilová-Sulková S, Marek J, Justová V, Lacinová Z, Haluzík M, Haas T, Krsek M.
- 314 __
- $a Third Department of Medicine, First Faculty of Medicine, Charles University, U nemocnice 1, 128 08 Prague 2, Czech Republic
- 520 9_
- $a Ghrelin was originally isolated from the rat stomach and significant amounts were found also in the kidney. Present study was designed to examine changes in ghrelin levels in renal failure and their relationship to the GH/IGF-I axis. Fourty patients with mild-to-severe CRF (19 men, 21 women, aged 62.5 +/- 2.2 years, BMI 27.57 +/- 0.73 kg/m(2)) and 34 healthy control subjects (17 men, 17 women, aged 60 +/- 2.6 years, BMI 27.55 +/- 0.79 kg/m(2)) were included in the study. Total ghrelin levels were significantly increased in patients with chronic renal failure (CRF) (p < 0.0001). Total ghrelin in CRF correlated positively with active ghrelin (p < 0.001), GH (p < 0.05), IGF-I (p < 0.05), free IGF-I (p = 0.0001), IGFBP-3 (p < 0.01), IGFBP-2 and -6 (p < 0.05). Active ghrelin in CRF correlated positively with IGF-I (p < 0.001), free-IGF-I (p < 0.005), IGFBP-2 (p < 0.05) and IGFBP-3 (p < 0.05). However, most of the correlation were markedly reduced and the significance disappeared after adjustment for different creatinine levels. Hemodialysis in patients with end stage renal disease (ESRD) resulted in a significant reduction of plasma total and active ghrelin (p < 0.01 and p < 0.001 respectively). In conclusion we demonstrated elevated plasma levels of total ghrelin in CRF, and a reduction of total and active ghrelin after a single course of hemodialysis in ESRD. The elevation of ghrelin levels could be caused by impaired clearance and/or metabolism of ghrelin in the kidney. We did not prove clearly significant relationship between ghrelin serum levels and parameters of GH/IGF-I axis in study subjects.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a kreatin $x krev $7 D003401
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a ghrelin $7 D054439
- 650 _2
- $a růstový hormon $x metabolismus $7 D013006
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a protein 2 vázající insulinu podobné růstové faktory $x metabolismus $7 D018971
- 650 _2
- $a IGFBP-3 $x metabolismus $7 D018972
- 650 _2
- $a insulinu podobný růstový faktor I $x metabolismus $7 D007334
- 650 _2
- $a ledviny $x metabolismus $7 D007668
- 650 _2
- $a renální insuficience $x krev $7 D051437
- 650 _2
- $a chronické selhání ledvin $x krev $x metabolismus $7 D007676
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a statistické modely $7 D015233
- 650 _2
- $a peptidové hormony $x chemie $x krev $x metabolismus $7 D036361
- 650 _2
- $a receptory buněčného povrchu $x chemie $7 D011956
- 650 _2
- $a leptinové receptory $7 D054411
- 650 _2
- $a dialýza ledvin $7 D006435
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Hodková, Magdaléna. $7 _AN030523
- 700 1_
- $a Sazamová, Magda $7 xx0128462
- 700 1_
- $a Rosická, Martina $7 xx0061797
- 700 1_
- $a Sulková, Sylvie, $d 1954- $7 jn20000710614
- 700 1_
- $a Marek, Josef, $d 1936-2019 $7 nlk19990073526
- 700 1_
- $a Justová, Vlasta $7 xx0099628
- 700 1_
- $a Lacinová, Zdeňka $7 xx0062138
- 700 1_
- $a Haluzík, Martin, $d 1970- $7 xx0000707
- 700 1_
- $a Haas, Tomáš $7 xx0047240
- 700 1_
- $a Kršek, Michal $7 xx0046428
- 773 0_
- $w MED00005163 $t Growth hormone & IGF research $g Roč. 15, č. 6 (2005), s. 369-376 $x 1096-6374
- 910 __
- $a ABA008 $b x $y 9
- 990 __
- $a 20090310084605 $b ABA008
- 991 __
- $a 20130225090552 $b ABA008
- 999 __
- $a ok $b bmc $g 637985 $s 490782
- BAS __
- $a 3
- BMC __
- $a 2005 $b 15 $c 6 $d 369-376 $i 1096-6374 $m Growth hormone & IGF research $x MED00005163
- GRA __
- $a NB7099 $p MZ0
- LZP __
- $a 2009-B2/ipme